MEBIS, Jeroen

Email Alert RSS Feed

Profile

Full Name
MEBIS, Jeroen
Email
jeroen.mebis@uhasselt.be
 
Loading... 5 0 5 0 false
Loading... 6 0 5 0 false

Publications

Refined By:
Author:  Canon, J-L.

Results 1-4 of 4 (Search time: 0.002 seconds).

Issue DateTitleContributor(s)TypeCat.
12023Afatinib for EGFR, HER2 or HER3 mutated solid tumors: A phase II Belgian precision studyDecoster, L.; Aftimos, P. G.; Rottey, S.; Prenen, H.; Collignon, J. J.; MEBIS, Jeroen; Canon, J-L.; Fastenaekels, V.; Cappoen, N.; Joris, S. R.; De Greve, J.Journal ContributionM
22023GeNeo: Agnostic comprehensive genomic profiling versus limited panel organ-directed next-generation sequencing within the Belgian PRECISION initiativeAftimos, P. G.; Punie, K.; Decoster, L.; de Lummen, C. Van Marcke; Hebrant, A.; Raicevic, G.; Van Valckenborgh, E.; MAES, Brigitte; Maetens, J.; Collignon, J. J.; van den Mooter, T. F. A.; Fried-Vermeij, J.; Demey, W.; Tejpar, S.; Peeters, M.; Canon, J-L.; Lybaert, W.; MEBIS, Jeroen; Rottey, S.; De Greve, J.Journal ContributionM
32023Efficacy of olaparib in advanced cancers with germline or somatic tumor mutations in BRCA1, BRCA2, CHEK2 and ATM: A Belgian precision tumor-agnostic phase II studyJoris, S. R.; Denys, H.; Collignon, J. J.; Rasschaert, M.; de Roodenbeke, D. T'Kint; Duhoux, F. P.; Canon, J-L.; Tejpar, S.; MEBIS, Jeroen; Decoster, L.; Aftimos, P. G.; De Greve, J.Journal ContributionM
42021Efficacy of olaparib in advanced cancers occurring in patients with germline or somatic tumor mutations in homologous recombination (HR) genes, a Belgian Precision phase II basket studyJoris, S.; Denys, H.; Martin, M.; de Roodenbeke, D. t'Kint; Duhoux, F.; Berchem, G.; Punie, K.; Bols, A.; MEBIS, Jeroen; Canon, J-L.; Decoster, L.; De Greve, J.Journal ContributionM